The short- and medium-term results of transcatheter closure of atrial septal defect with severe pulmonary arterial hypertension

Heart and Vessels

Volumn 27, Issue 6, 2012, Pages 603-609

  Huang, Zhi Wei ^a   Fan, Zhi Xin ^a   Sun, Jian Tao ^a   Li, Wei Min ^a   Gao, Yan Qing ^a   Quan, Yi Hua ^a   Geng, Ya Ming ^a   Niu, Yan Yan ^a   Wu, Bing Xiang ^a  

^a THE FIRST AFFILIATED HOSPITAL OF HARBIN MEDICAL UNIVERSITY   (China)

Author keywords

Atrial septal defect; Congenital heart disease; Pulmonary arterial hypertension; Transcatheter closure

Indexed keywords

ILOPROST; VARDENAFIL; DIAGNOSTIC AGENT;

ADULT; AGED; ATRIAL SEPTAL OCCLUDER; BLOOD VESSEL REACTIVITY; CLINICAL EXAMINATION; DISEASE ASSOCIATION; DISEASE SEVERITY; ECHOCARDIOGRAPHY; FEMALE; HEART ATRIUM SEPTUM DEFECT; HEART CATHETERIZATION; HEART HEMODYNAMICS; HUMAN; LUNG ARTERY PRESSURE; LUNG VASCULAR RESISTANCE; MAJOR CLINICAL STUDY; MALE; PATIENT SAFETY; PATIENT SELECTION; PRIORITY JOURNAL; PULMONARY HYPERTENSION; REVIEW; TREATMENT OUTCOME; WALKING; AEROSOL; ARTERIAL PRESSURE; ARTICLE; CASE REPORT; CHI SQUARE DISTRIBUTION; CONVALESCENCE; ECHOGRAPHY; EXERCISE TEST; EXERCISE TOLERANCE; HEART SEPTUM DEFECT; INHALATIONAL DRUG ADMINISTRATION; INSTRUMENTATION; MIDDLE AGED; PATHOPHYSIOLOGY; PREDICTIVE VALUE; PULMONARY ARTERY; RETROSPECTIVE STUDY; SEPTAL OCCLUDER; SEVERITY OF ILLNESS INDEX; SWAN GANZ CATHETER; TIME; VASCULAR RESISTANCE;

ADMINISTRATION, INHALATION; ADULT; AEROSOLS; AGED; ARTERIAL PRESSURE; CARDIAC CATHETERIZATION; CATHETERIZATION, SWAN-GANZ; CHI-SQUARE DISTRIBUTION; EXERCISE TEST; EXERCISE TOLERANCE; FEMALE; HEART SEPTAL DEFECTS, ATRIAL; HUMANS; HYPERTENSION, PULMONARY; ILOPROST; MALE; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; PULMONARY ARTERY; RECOVERY OF FUNCTION; RETROSPECTIVE STUDIES; SEPTAL OCCLUDER DEVICE; SEVERITY OF ILLNESS INDEX; TIME FACTORS; TREATMENT OUTCOME; VASCULAR RESISTANCE; WALKING; YOUNG ADULT;

EID: 84876543307     PISSN: 09108327     EISSN: 16152573     Source Type: Journal    
DOI: 10.1007/s00380-011-0187-4     Document Type: Review

References (29)

1. Barst RJ, McGoon M, Torbicki A, Sitbon O, Krowka MJ, Olschewski H, Gaine S (2004) Diagnosis and differential assessment of pulmonary arterial hypertension. J Am Coll Cardiol 43:40S-47S
2. Humbert M, Sitbon O, Chaouat A, Bertocchi M, Habib G, Gressin V, Yaici A, Weitzenblum E, Cordier JF, Chabot F, Dromer C, Pison C, Reynaud-Gaubert M, Haloun A, Laurent M, Hachulla E, Simonneau G (2006) Pulmonary arterial hypertension in France: results from a national registry. Am J Respir Crit Care Med 173:1023-1030
3. Bush A, Busst CM, Haworth SG, Hislop AA, Knight WB, Corrin B, Shinebourne EA (1988) Correlations of lung morphology, pulmonary vascular resistance, and outcome in children with congenital heart disease. Br Heart J 59:480-485
4. Vincens JJ, Temizer D, Post JR, Edmunds LH Jr, Herrmann HC (1995) Long-term outcome of cardiac surgery in patients with mitral stenosis and severe pulmonary hypertension. Circulation 9(II):137-142
5. Yan C, Zhao S, Jiang S, Xu Z, Huang L, Zheng H, Ling J, Wang C, Wu W, Hu H, Zhang G, Ye Z, Wang H (2007) Transcatheter closure of patent ductus arteriosus with severe pulmonary arterial hypertension in adults. Heart 93:514-518
6. O'Donnell C, Ruygrok PN, Whyte K, Wilson NJ (2010) Progressive pulmonary hypertension post atrial septal defect device closure - early symptomatic improvement may not predict outcome. Heart Lung Circ 19:713-716
7. Schwerzmann M, Zafar M, McLaughlin PR, Chamberlain DW, Webb G, Granton J (2006) Atrial septal defect closure in a patient with "irreversible" pulmonary hypertensive arteriopathy. Int J Cardiol 110:104-107
8. Imanaka K, Kotsuka Y, Takamoto S, Furuse A, Inoue K, Shirai T (1998) Atrial septal defect and severe pulmonary hypertension in an adult who needed nitric oxide inhalation after repair. Kyobu Geka 51:403-405
9. Mizuhara A, Ino T, Adachi H, Ide H, Yamaguchi A, Kawahito K (1993) Surgical treatment of adult secundum ASD with severe pulmonary hypertension - two case reports. Nippon Kyobu Geka Gakkai Zasshi 41:1089-1093
10. Brooks D, Solway S, Gibbons WJ (2002) ATS statement: guidelines for the six-minute walk test. ATS Committee on Proficiency Standards for Clinical Pulmonary Function Laboratories. Am J Respir Crit Care Med 166:111-117
11. Sun WF, Dong ZF, Gong K, Zhang GP, Cui T, Xia YD, Dong J, Shen Y (2010) Transcatheter closure with use of the SHSMA occluder in 180 patients with congenital heart defects preliminary results. Tex Heart Inst J 37:531-537
12. Fujita H, Fukumoto Y, Saji K, Sugimura K, Demachi J, Nawata J, Shimokawa H (2010) Acute vasodilator effects of inhaled fasudil, a specific Rho-kinase inhibitor, in patients with pulmonary arterial hypertension. Heart Vessels 25:144-149
13. Rimensberger PC, Spahr-Schopfer I, Berner M, Jaeggi E, Kalangos A, Friedli B, Beghetti M (2001) Inhaled nitric oxide versus aerosolized iloprost in secondary pulmonary hypertension in children with congenital heart disease: vasodilator capacity and cellular mechanisms. Circulation 103:544-548
14. Limsuwan A, Khosithseth A, Wanichkul S, Khowsathit P (2009) Aerosolized iloprost for pulmonary vasoreactivity testing in children with long-standing pulmonary hypertension related to congenital heart disease. Catheter Cardiovasc Interv 73:98-104
15. Berger M, Haimowitz A, Van Tosh A, Berdoff RL, Goldberg E (1985) Quantitative assessment of pulmonary hypertension in patients with tricuspid regurgitation using continuous wave Doppler ultrasound. J Am Coll Cardiol 6:359-365
16. McLaughlin VV, Archer SL, Badesch DB, Barst RJ, Farber HW, Lindner JR, Mathier MA, McGoon MD, Park MH, Rosenson RS, Rubin LJ, Tapson VF, Varga J, Harrington RA, Anderson JL, Bates ER, Bridges CR, Eisenberg MJ, Ferrari VA, Grines CL, Hlatky MA, Jacobs AK, Kaul S, Lichtenberg RC, Lindner JR, Moliterno DJ, Mukherjee D, Pohost GM, Rosenson RS, Schofield RS, Shubrooks SJ, Stein JH, Tracy CM, Weitz HH, Wesley DJ (2009) ACCF/AHA 2009 expert consensus document on pulmonary hypertension: a report of the American College of Cardiology Foundation taskforce on expert consensus documents and the American Heart Association. Circulation 119:2250-2294
17. Diller GP, Gatzoulis MA (2007) Pulmonary vascular disease in adults with congenital heart disease. Circulation 115:1039-1050
18. Galiè N, Torbicki A, Barst R, Dartevelle P, Haworth S, Higenbottam T, Olschewski H, Peacock A, Pietra G, Rubin LJ, Simonneau G (2004) Guidelines on diagnosis and treatment of pulmonary arterial hypertension. Guidelines on diagnosis and treatment of PAH. The Task Force on Diagnosis and Treatment of Pulmonary Arterial Hypertension of the European Society of Cardiology. Eur Heart J 25:2243-2278
19. Balint OH, Samman A, Haberer K, Tobe L, McLaughlin P, Siu SC, Horlick E, Granton J, Silversides CK (2008) Outcomes in patients with pulmonary hypertension undergoing percutaneous atrial septal defect closure. Heart 94:1189-1193
20. de Lezo JS, Medina A, Romero M, Pan M, Segura J, Caballero E, Pavlovic D, Ortega JR, Franco M, Delgado A, Ojeda S, Mesa D, Lafuente M (2002) Effectiveness of percutaneous device occlusion for atrial septal defect in adult patients with pulmonary hypertension. Am Heart J 144:877-880
21. Yong G, Khairy P, De Guise P, Dore A, Marcotte F, Mercier LA, Noble S, Ibrahim R (2009) Pulmonary arterial hypertension in patients with transcatheter closure of secundum atrial septal defects: a longitudinal study. Circ Cardiovasc Interv 2:455-462
22. Konstantinides S, Geibel A, Olschewski M, Görnandt L, Roskamm H, Spillner G, Just H, Kasper W (1995) A comparison of surgical and medical therapy for atrial septal defect in adults. N Engl J Med 333:469-473
23. Humenberger M, Rosenhek R, Gabriel H, Rader F, Heger M, Klaar U, Binder T, Probst P, Heinze G, Maurer G, Baumgartner H (2011) Benefit of atrial septal defect closure in adults: impact of age. Eur Heart J 32:553-560
24. Yock PG, Popp RL (1984) Noninvasive estimation of right ventricular systolic pressure by Doppler ultrasound in patients with tricuspid regurgitation. Circulation 70:657-662
25. Murata I, Kihara H, Shinohara S, Ito K (1992) Echocardiographic evaluation of pulmonary arterial hypertension in patients with progressive systemic sclerosis and related syndromes. Jpn Circ J 56:983-991
26. Shapiro SM, Oudiz RJ, Cao T, Romano MA, Beckmann XJ, Georgiou D, Mandayam S, Ginzton LE, Brundage BH (1997) Primary pulmonary hypertension: improved long-term effects and survival with continuous intravenous epoprostenol infusion. J Am Coll Cardiol 30:343-349
27. Jing ZC, Jiang X, Wu BX, Xu XQ, Wu Y, Ma CR, Wang Y, Yang YJ, Pu JL, Gao W (2009) Vardenafil treatment for patients with pulmonary arterial hypertension: a multicentre, open-label study. Heart 95:1531-1536
28. Chang SA, Jang SY, Ki CS, Kang IS, Kim DK (2011) Successful bosentan therapy for pulmonary arterial hypertension associated with hereditary hemorrhagic telangiectasia. Heart Vessels 26:231-234
29. Dimopoulos K, Inuzuka R, Goletto S, Giannakoulas G, Swan L, Wort SJ, Gatzoulis MA (2010) Improved survival among patients with Eisenmenger syndrome receiving advanced therapy for pulmonary arterial hypertension. Circulation 121:20-25